Stock Groups

Moderna seeks COVID-19 vaccine booster clearance in older adults, high-risk individuals By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Syringes containing Moderna COVID-19 are placed on a table at Sarasota Memorial Hospital, Sarasota (Florida), U.S.A, September 24, 2021. REUTERS/Shannon Stapleton

(Reuters) – Moderna (NASDAQ:) Inc said Tuesday that the U.S. Food and Drug Administration should allow booster doses in COVID-19 vaccine for fully vaccinated elderly adults and other high risk individuals.

According to the company, its data support the public health benefits of booster vaccines that restore immunity and reduce the incidence of breakthrough infections among fully-vaccinated adults.

Moderna’s remarks were made public in briefing documents before a meeting of FDA’s external expert advisors on Thursday to discuss the booster dosage.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]